2023 will be a year of flexibility when it comes to your investing and trading strategy.If you hold onto a single rigid system of making money, it’s likely the market will flip next week and what you’re used to isn’t the reality anymore.
How Money Morning is setting up for 2023...
Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
Tech stocks have had a rough couple of months.While some were hit harder by the selloff than others, there's no denying that developing tech still presents a great opportunity that some benefit more from than others.
Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
The global semiconductor industry is expected to be worth over $600 billion in 2022.While it’s still trumped by the $10 trillion farming industry and the $5 trillion oil and gas industry, nearly 80% of all food or fuel doesn’t come from a mere handful of manufacturers.That gives chip stocks a unique edge.
Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
GlobalFoundries stock is going public on October 27 and will be listed on the Nasdaq under the ticker GFS.
The company is the self-proclaimed largest silicon wafer supplier that’s not dependent on China and Taiwan, but that doesn’t mean the business will be profitable.
Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
AMD and Nvidia are two of the hottest chip stocks on the market.
But if you can only buy one, there’s a clear winner.
Both Advanced Micro Devices (Nasdaq: AMD) and Nvidia (Nasdaq: AMD) are growing at a quick pace in 2021, thanks to the chip shortage that began in 2020.
So far, Nvidia is up 70% year to date.
And AMD has gained 45% since May.
This shortage pushed the cost of semiconductors higher and, in turn, drove the share price these companies higher.
But which chip stock is the best buy?
Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
It's unusual for an investor day to make much news.
But Nvidia's was a different thing altogether.
Nvidia stock is soaring now, and the biggest gains are still in the future.
Here's what has Wall Street so excited and why it's a buy now...
Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
There’s still one critical pandemic shortage that’s not only recovered, but has only gotten worse: Semiconductors.
That’s why the government’s preparing to spend billions to help solve the supply shortage in the sector.
And one firm’s in a really good position for savvy investors to capitalize on this scenario… .
Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
While Apple is known for disrupting entire industries, few expected it to send a shock wave toward semiconductor stocks.
But the Apple-designed M1 chip in its latest Macs will do just that.
The M1 is the first ARM-based processor to match the muscle of an Intel CPU.
But the M1 achieves this feat while using far less energy.
This is an unprecedented threat to Intel but opens a window of opportunity to several chipmakers.
Today we call the winners and losers…
Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
When it comes to investing, it's difficult to find the next big thing.
Companies like Amazon (NASDAQ: AMZN), Zoom (NASDAQ: ZOOM) and Teladoc (NYSE: TDOC) have all been media darlings, but I'm focusing on a completely different space.
The fact is, consolidation is fueling growth in the semiconductor market.
That's why we have seen as much M&A in the semiconductor market this year as we have had in the past three years combined.
These deals are creating cross-sell opportunities and improving manufacturing as they scale up.
While these deals I just mentioned were the largest semiconductor deals of the year, I'm looking at what could be one of the biggest opportunities as two more companies join forces.
Here's why that makes AMD stock one of my favorite tech plays right now...
Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
"Lead, follow, or get out of the way."
This is one of those well-known aphorisms that's been around forever – though its originator is unknown.
Truth be told, it doesn't matter who said it first. It's a great bit of advice.
Especially as we interpret it.
In our investment work here at Money Morning, we always seek to lead Wall Street and the rest of the packrat investment crowd.
We never follow, especially since "the crowd" tends to be indecisive, late to the gun – or flat out wrong.
And we always get out of the way – sidestepping the dust-rising thump that's an inevitable result of the miscues and sins of the Wall Street Goliath.
It's a simple formula. And a successful one.
And it's the reason we keep outperforming "the crowd."
Like the 2,067% gain on biotech Galapagos NV, the very first stock I recommended on the very first day I published my Member-based service, Private Briefing, back in August 2011.
My readers also pulled down peak gains of more than 2,892% in Nvidia, 2,828% in Advanced Micro Devices, 818% in biotech buyout Pharmacyclics, and more.
Today, I've decided to share my latest insight on one of my big biotech winners with Money Morning readers because the opportunity is too good to keep to ourselves. And since my colleague Michael Robinson recently talked about 2020's record-crushing biotech IPOs, it's the perfect time to share this.
The company I'm showing you today is essential to biotech stocks. It's a "biotech-enabler" that's zoomed 1,755% since I first told my readers about it back in June 2013.
In 2013, it was trading at $8.14.
It closed July 30 at $151.25 – not long after Investor's Business Daily said the stock had entered a "Buy Zone."
True, but where were they seven years and 1,755% ago?
Of course, what's important now is what comes next – and it's clear this stock's run isn't over… Full Story
Start the conversation